1620 Investment Advisors »

Neurocrine Biosciences shares owned by 1620 Investment Advisors

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by 1620 Investment Advisors from 13F filings

Historical chart of 1620 Investment Advisors investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by 1620 Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by 1620 Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $100k 867 115.22
2024-06-30 $118k 857 137.67

More positions owned by 1620 Investment Advisors

SPDR Portfolio Intrmdt Term Corp Bd ETF Etf (SPIB)
iShares 7-10 Year Treasury Bond ETF Etf (IEF)
SPDR MSCI EAFE StrategicFactors ETF Etf (QEFA)
SPDR S&P 600 Small Cap ETF Etf
Tri Continental Corporation Etf (TY)
SPDR Ptf Short-Term Treasury ETF Etf (SPTS)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
TJX Companies (TJX)
iShares Short Term Ntnl Muni Bond ETF Etf (SUB)
iShares Short-Term Corporate Bond ETF Etf (IGSB)
Microsoft Corporation (MSFT)
Freedom 100 Emerging Markets ETF Etf (FRDM)
Schwab U.S. TIPS ETF Etf (SCHP)
SPDR Doubleline Total Return Tactical ETF Etf (TOTL)

View all positions for 1620 Investment Advisors

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
State Street Corporation
Dodge & Cox
Citadel Advisors
Renaissance Technologies
AQR Capital Management
Geode Capital Management
Bellevue Group
Morgan Stanley
T. Rowe Price Associates
Wellington Management Company
Jpmorgan Chase & Co
Ubs Global Asset Management Americas
Goldman Sachs Group

View all funds holding Neurocrine Biosciences